NP / PA
Gurney, Rebecca
Gurney, Rebecca was paid $140K by Medicaid between Dec 2018 and Apr 2022, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoGURNEY, REBECCA
PALMER, MA 01069
PALMER, MA 01069
33aNPI1265830764assigned 12/15/2014
33bProvider typeFamily Nurse Practitioner
28Total paid$140K
24GClaims3,157
24DCodes billed14
24AFirst – last monthDec 2018 – Apr 2022
Compared with peers
Next to other Family Nurse Practitioner providers in Massachusetts
Rank by total paid#28 of 327
Median peer was paid$5K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31 | $2K | |
| 2019 | 792 | $35K | |
| 2020 | 588 | $30K | |
| 2021 | 1,204 | $56K | |
| 2022 | 542 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 1,149 | 1,117 | $64K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 298 | 291 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 15% | 422 | 415 | $21K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.9% | 423 | 416 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.7% | 209 | 206 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.3% | 61 | 61 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.8% | 60 | 60 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 113 | 111 | $1K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 133 | 133 | $1K |
| 96127 | <1% | 53 | 50 | $682.96 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 37 | 36 | $447.47 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | 13 | $412.21 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.